Degree of myopia connected to birth weight and ROP severity

Article

Retinopathy of prematurity (ROP) and birth weight are strongly linked to degree of myopia in children.

Retinopathy of prematurity (ROP) and birth weight are strongly linked to degree of myopia in children, according to a paper featured in the Journal of Optometry.

Dr Bariah Mohd-Ali et al., Optometry Department, Faculty of Allied Health Sciences, Universiti Kebangsaan, Kuala Lumpur, Malaysia, conducted a retrospective review on 102 clinical records of preterm babies born between the years 2000 and 2008.

The information gathered included gender, race, age at birth, current age, birth weight, current weight, fundus examination records, visual acuity (VA), refraction and strabismus. Follow-up data from 1 to 6 years of age was also used in the investigation. Average birth weight was 1.37 ± 0.36 kg and average gestational age was 30.83 ± 2.42 weeks.

It was found that 38 of the 102 children had ROP and 64 didn't have ROP. Children with ROP developed myopia and children without ROP commonly developed hyperopia. Also, a significant improvement in VA was recorded as the children aged.

The study strongly suggests the consideration of birth weight and presence of ROP in children during the screening of vision and refractive error.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.